Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for StimCell Energetics Inc. (STME : OTC)

• Company Description    StimCell Energetics Inc. is a biotech company, which is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products which enhance cellular function, promote general wellness and alleviate health complications including, but not limited to aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. StimCell Energetics Inc. is based in VANCOUVER, Canada. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.22 Daily Weekly Monthly 20 Day Moving Average: 2,529 shares Shares Outstanding: 21.14 (millions) Market Capitalization: $4.65 (millions) Beta: 52 Week High: $0.48 52 Week Low: $0.18 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -26.67% -25.59% 12 Week -36.78% -38.57% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1130 PENDER STREET WEST SUITE 555 - VANCOUVER,A1 V6E 4A4 CAN ph: 844-238-2692 fax: - None https://stimcell.com

• General Corporate Information    Officers David Jeffs - Chief Executive Officer and Director Yanika Silina - Chief Financial Officer Joao (John) Da Costa - Directors Amir Vahabzadeh - Directors George Adams - Directors Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 15115X206 SIC: 3841 Fiscal Year Fiscal Year End: May Last Reported Quarter: 05/01/26 Next Expected EPS Date: 11/30/26 Share - Related Items Shares Outstanding: 21.14 Most Recent Split Date: (:1) Beta: Market Capitalization: $4.65 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.04 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/30/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 08/31/26 - - 05/31/26 - - 02/28/26 - - ROA 08/31/26 - - 05/31/26 - -1,939.43 02/28/26 - -2,845.88 Current Ratio 08/31/26 - - 05/31/26 - 0.04 02/28/26 - 0.02 Quick Ratio 08/31/26 - - 05/31/26 - 0.04 02/28/26 - 0.02 Operating Margin 08/31/26 - - 05/31/26 - - 02/28/26 - - Net Margin 08/31/26 - - 05/31/26 - - 02/28/26 - - Pre-Tax Margin 08/31/26 - - 05/31/26 - - 02/28/26 - - Book Value 08/31/26 - - 05/31/26 - -0.09 02/28/26 - -0.08 Inventory Turnover 08/31/26 - - 05/31/26 - - 02/28/26 - - Debt-to-Equity 08/31/26 - - 05/31/26 - - 02/28/26 - - Debt-to-Capital 08/31/26 - - 05/31/26 - - 02/28/26 - -

Powered by Zacks Investment Research ©